Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

BioDelivery Sciences reports preliminary phase I data on BEMA-buprenorphine/naloxone

Sep. 7, 2011

Duloxetine blocks psychostimulant effects

Sep. 5, 2011

Titan Pharmaceuticals schedules pre-NDA meeting for Probuphine

Sep. 1, 2011

ALL-00179 allows transdermal delivery of cannabidiol with microneedles

Aug. 22, 2011

PharmAthene receives Department of Defense contract for nerve agent medical countermeasure program

Aug. 17, 2011

First specific treatment for scorpion stings approved in U.S.

Aug. 5, 2011

Heroin-like immunoconjugate protects against addiction

Aug. 2, 2011

Beta-adrenoceptor antagonist prevents retrieval of cocaine-associated memory in rats

July 28, 2011

Nabi Biopharmaceuticals reports on first confirmatory phase III NicVAX study

July 19, 2011

Titan Pharmaceuticals reports topline results from phase III Probuphine trial

July 13, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...